European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- PMID: 30324412
- PMCID: PMC7026233
- DOI: 10.1007/s00198-018-4704-5
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Erratum in
-
Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int. 2020 Jan;31(1):209. doi: 10.1007/s00198-019-05184-3. Osteoporos Int. 2020. PMID: 31673731
-
Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int. 2020 Apr;31(4):801. doi: 10.1007/s00198-020-05303-5. Osteoporos Int. 2020. PMID: 32072205 Free PMC article.
Abstract
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis.
Introduction: The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2013. This manuscript updates these in a European setting.
Methods: Systematic reviews were updated.
Results: The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; monitoring of treatment; assessment of fracture risk; case-finding strategies; investigation of patients; health economics of treatment. The update includes new information on the evaluation of bone microstructure evaluation in facture risk assessment, the role of FRAX® and Fracture Liaison Services in secondary fracture prevention, long-term effects on fracture risk of dietary intakes, and increased fracture risk on stopping drug treatment.
Conclusions: A platform is provided on which specific guidelines can be developed for national use.
Keywords: Bone mineral density; Diagnosis of osteoporosis; FRAX; Fracture risk assessment; Health economics; Treatment of osteoporosis.
Conflict of interest statement
JAK reports grants from Amgen, Eli Lilly and Radius Health; non-financial support from Medimaps, and Asahi; and other support from AgNovos. JAK is the architect of FRAX® but has no financial interest. CC reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. RR has received consulting fees or advisory board fees from Radius Health, Labatec, Danone, Nestlé, CNIEL and Sandoz. J-YR has received advisory board or consulting fees from IBSA-Genévrier, Pierre Fabre, Radius Health, TEVA and Mylan; and lecture fees from Anovos, IBSA-Genévrier, Mylan, CNIEL, Dairy Research Council (DRC) and Theramex; and institutional grant support from IBSA-Genévrier, Mylan, CNIEL and Radius Health.
Figures
Similar articles
-
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19. Osteoporos Int. 2013. PMID: 23079689 Free PMC article.
-
Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Aging Clin Exp Res. 2019 Jan;31(1):15-17. doi: 10.1007/s40520-018-1109-4. Epub 2019 Jan 5. Aging Clin Exp Res. 2019. PMID: 30612282
-
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Osteoporos Int. 2008. PMID: 18266020 Free PMC article. Review.
-
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Calcif Tissue Int. 2019 Mar;104(3):235-238. doi: 10.1007/s00223-018-00512-x. Calcif Tissue Int. 2019. PMID: 30796490 Free PMC article. Review.
-
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.Osteoporos Int. 2020 Jan;31(1):1-12. doi: 10.1007/s00198-019-05176-3. Epub 2019 Nov 13. Osteoporos Int. 2020. PMID: 31720707 Free PMC article.
Cited by
-
Disparities in management of symptomatic osteoporotic vertebral compression fractures: a nationwide multidisciplinary survey.Arch Osteoporos. 2024 Oct 23;19(1):101. doi: 10.1007/s11657-024-01454-8. Arch Osteoporos. 2024. PMID: 39441383
-
The effect of body mass index on bone density by age distribution in women.Medicine (Baltimore). 2024 Oct 18;103(42):e40129. doi: 10.1097/MD.0000000000040129. Medicine (Baltimore). 2024. PMID: 39432611 Free PMC article.
-
A novel clinical prediction model for hip fractures: a development and validation study in the total population of Sweden.EClinicalMedicine. 2024 Oct 5;77:102877. doi: 10.1016/j.eclinm.2024.102877. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39430614 Free PMC article.
-
Under-Prescription of Drugs in the Elderly Population of Western Romania: An Analysis Based on STOPP/START Version 2 Criteria.J Clin Med. 2024 Oct 8;13(19):5970. doi: 10.3390/jcm13195970. J Clin Med. 2024. PMID: 39408034 Free PMC article.
-
Relationship between serum level of miR-338-3p and miR-105-3p and bone metabolic markers in patients with diabetes nephropathy.Ren Fail. 2024 Dec;46(2):2406390. doi: 10.1080/0886022X.2024.2406390. Epub 2024 Oct 8. Ren Fail. 2024. PMID: 39378116 Free PMC article.
References
-
- Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1997;7:390–406. - PubMed
-
- Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24:23–57. - PMC - PubMed
-
- Hernlund E, Svedbom A, Ivergård M, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Archives of Osteoporosis 8:136. 10.1007/s11657-013-0136-1. Access: http://www.iofbonehealth.org/data-publications/regional-audits/osteoporo... Accessed 4 Jan 2018 - PMC - PubMed
-
- Kanis JA, Svedbom A, Harvey N, McCloskey EV. The osteoporosis treatment gap. J Bone Miner Res. 2014;29:1926–1928. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
